However, it can also be an overestimation due to greater genetic testing among persons with a higher risk of SMA, a high rate of foetal death due to the disease severity, and lethality of the absence of SMN1 and its homologue SMN2, absent in 10–15% of the general population [16]. Here, SMN2 is linked to proximal spinal muscular atrophy.